VORNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Vor Biopharma Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$18.04+0.01 (+0.06%)
Close on Oct 19, 2026
- Market cap
- $979.65M
- P/E (TTM)
- –
- Dividend yield
- –
Vor Biopharma statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison
Valuation
| Measure | Vor Biopharma | Industry median |
|---|---|---|
| Market Cap | $1.07B | $166.30M |
| Enterprise Value | $601.19M | $88.19M |
Income (trailing twelve months)
| Measure | Vor Biopharma | Industry median |
|---|---|---|
| Operating Income | -$147.08M | -$21.40M |
| Net Income | $627.78M | -$22.46M |
| EBITDA | -$147.08M | -$16.91M |
Returns
| Measure | Vor Biopharma | Industry median |
|---|---|---|
| Return on Assets (ROA) | 182.9% | -40.9% |
| Return on Capital Employed (ROCE) | -32.2% | -38.1% |
Balance sheet
| Measure | Vor Biopharma | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $466.10M | $61.43M |
| Net Cash (Debt) | $466.10M | $15.35M |
| Net Cash Per Share | $7.88 | $0.66 |
| Equity (Book Value) | -$200.20M | $49.09M |
| Book Value Per Share | -$3.38 | $1.37 |
| Tangible Book Value | -$200.20M | $23.52M |
| Working Capital | $450.29M | $76.81M |
Financial position
| Measure | Vor Biopharma | Industry median |
|---|---|---|
| Current Ratio | 19.15 | 3.34 |
| Quick Ratio | 18.78 | 2.44 |
Cash flow (trailing twelve months)
| Measure | Vor Biopharma | Industry median |
|---|---|---|
| Operating Cash Flow | -$140.09M | -$12.35M |
| Capital Expenditures | -$726.00K | -$1.08M |
| Free Cash Flow | -$140.81M | -$20.22M |
| FCF Per Share | -$2.38 | -$0.42 |
Efficiency
| Measure | Vor Biopharma | Industry median |
|---|---|---|
| Profits Per Employee | $8.26M | -$703.34K |
| Employee Count | 76 | 74 |
Dividends and yields
| Measure | Vor Biopharma | Industry median |
|---|---|---|
| Earnings Yield | 58.8% | -23.3% |
| FCF Yield | -13.2% | -8.72% |
Shares
| Measure | Vor Biopharma | Industry median |
|---|---|---|
| Shares Outstanding | 59,162,300 | 58,127,000 |
| Shares Change (QoQ) | 0.50% | 0.54% |
| Shares Held by Institutions | 83.4% | 59.4% |
Scores
| Measure | Vor Biopharma | Industry median |
|---|---|---|
| Altman Z-Score | -3.12 | -0.22 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from Vor Biopharma's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.